id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-267436-mivxm8oh	Groneberg, David A	Treatment and vaccines for severe acute respiratory syndrome	2005-03-10		.txt	text/plain	5918	229	36	The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen A cluster of cases of severe acute respiratory syndrome in Hong Kong A major outbreak of severe acute respiratory syndrome in Hong Kong Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China Severe acute respiratory syndromerelated coronavirus is inhibited by interferon-alpha Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Severe acute respiratory syndrome-associated coronavirus in lung tissue Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Novel peptide inhibitors of angiotensin-converting enzyme 2 Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA Modulation of HIV-1 replication by RNA interference Interference of hepatitis C virus RNA replication by short interfering RNAs Short interfering RNA-directed inhibition of hepatitis B virus replication Silencing SARS-CoV spike protein expression in cultured cells by RNA interference Inhibition of SARS-associated coronavirus infection and replication by RNA interference Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma Induction of inducible nitric oxide synthase and proinflammatory cytokines expression by o,pЈ-DDT in macrophages Inhibition of SARS-CoV infection in vitro by S-nitroso-Nacetylpenicillamine, a nitric oxide donor compound Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness Role of nitric oxide in chronic allergen-induced airway cell proliferation and inflammation Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide Small molecules targeting severe acute respiratory syndrome human coronavirus Pro/con clinical debate: steroids are a key component in the treatment of SARS Lung pathology of fatal severe acute respiratory syndrome Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome Fatal aspergillosis in a patient with SARS who was treated with corticosteroids SARS: prognosis, outcome and sequelae Avascular necrosis of bone in severe acute respiratory syndrome Role of interferons in the treatment of severe acute respiratory syndrome Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs Interferon-beta 1a and SARS coronavirus replication Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques How the SARS vaccine effort can learn from HIVspeeding towards the future, learning from the past Treatment of severe acute respiratory syndrome with convalescent plasma Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets Caution urged on SARS vaccines A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination Effects of a SARS-associated coronavirus vaccine in monkeys Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice Nucleic acid vaccines: an overview A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus Induction of SARS-nucleoproteinspecific immune response by use of DNA vaccine SARS-one year later Seasonality of infectious diseases and severe acute respiratory syndrome-what we don't know can hurt us Clinical trials and novel pathogens: lessons learned from SARS Preparing to prevent severe acute respiratory syndrome and other respiratory infections Collateral damage: the unforeseen effects of emergency outbreak policies Support from the Deutsche Atemwegsliga and the German Research Foundation (DFG GR2014/2-1) to DAG is gratefully acknowledged. 13, 14 Evidence suggests that SARS coronavirus originated from SARS-like viruses in animals in the southern Chinese province of Guangdong; the most frequently implicated animal is the Himalayan palm civet, an animal found in food markets and eaten as a delicacy.	cache/cord-267436-mivxm8oh.txt	txt/cord-267436-mivxm8oh.txt
